SOURCE: Applied DNA Sciences
STONY BROOK, NY--(Marketwired - Apr 17, 2013) - Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that senior managers will lead important meetings this week concerning the company's SigNature® DNA marking program for electronics, currently required by the Defense Logistics Agency (DLA) for Federal Supply Class (FSC) 5962 microcircuits. The APDN SigNature DNA marking technology, which forensically protects against counterfeiting, has been gaining excitement and attention throughout the electronics industry. The platform will be explained by its most knowledgeable experts.
Janice Meraglia, Vice President of Government and Military Programs, and Bob MacDowell, Senior Sales Representative, will lead a workshop describing SigNature DNA marking. At a panel discussion focused on critical issues surrounding traceability in the supply chain, scheduled speakers are Dr. James A. Hayward, CEO and President of Applied DNA Sciences, Christine Metz, Chief of the Technical and Quality Policy Division for DLA Logistics Operations (Defense Logistics Agency), Tom Sharpe, Vice President of SMT Corp., Dave Loaney, CEO of Premier Semiconductor Service, and John Tomaszewicz, Quality Assurance Manager, Avnet USI. Please see below for time and place of these events.
"Signature DNA has been the subject of countless articles, meetings, blog posts and comments," observed Ms. Meraglia, "This is a chance to understand the platform factually and objectively, from the people who created it."
Applied DNA Sciences offers a botanical DNA taggant solution for the electronics industry that forensically prevents counterfeits from entering the supply chain. The U.S. Defense Logistics Agency clause 52.211-9074 requires SigNature DNA to be applied on all FSC 5962 microcircuits, which have been determined to be at high risk of counterfeiting. APDN also emphasizes the value of its SigNature DNA platform beyond the FSC 5962 category, including in other FSC classes and for commercial product. SigNature DNA marking adds a forensic layer of protection to the electronic component supply chain and complements existing best practices and accepted industry standards.
The ERAI Executive Conference is a noted forum for thought leaders in the electronics trades on supply chain subjects. Its theme for 2013 is: "Gaining Momentum - Supply Chain Advancements in the Fight Against Counterfeits." The two-day conference will include lectures, panel and round table discussions and interactive workshops led by subject matter experts from industry, government and academia.
Save the date!
ERAI Executive Conference
April 18-19, 2013
Rosen Centre Hotel
Panel: Traceability in the Age of Globalization
When: Thursday, April 18, 10:45 AM - 12:00 PM
- Dr. James A. Hayward, CEO and President of Applied DNA Sciences
- Christine Metz, Chief of the Technical and Quality Policy division for DLA Logistics Operations (Defense Logistics Agency)
- Tom Sharpe, Vice President of SMT Corp.
- Dave Loaney, CEO of Premier Semiconductor Service
- John Tomaszewicz, Quality Assurance Manager, Avnet USI.
Workshop: SigNature® DNA Marking and Forensic Authentication of Electronic Components
When: Thursday, April 18, 1:45 PM - 2:15 PM
Who: Janice Meraglia and Bob MacDowell
About Applied DNA Sciences
APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.
The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.